BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18550363)

  • 41. Role of 11β-OH-C(19) and C(21) steroids in the coupling of 11β-HSD1 and 17β-HSD3 in regulation of testosterone biosynthesis in rat Leydig cells.
    Latif SA; Shen M; Ge RS; Sottas CM; Hardy MP; Morris DJ
    Steroids; 2011 Jun; 76(7):682-9. PubMed ID: 21440566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 11
    Yang X; Hua W; Ryu S; Yates P; Chang C; Zhang H; Di L
    Drug Metab Dispos; 2018 Jul; 46(7):1023-1029. PubMed ID: 29674492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
    Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
    Maser E; Wsol V; Martin HJ
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of 11β-HSD1 dehydrogenase activity on bone histomorphometry of glucocorticoid-induced osteoporotic male Sprague-Dawley rats.
    Elvy Suhana MR; Farihah HS; Faizah O; Nazrun AS; Norazlina M; Norliza M; Ima-Nirwana S
    Singapore Med J; 2011 Nov; 52(11):786-93. PubMed ID: 22173247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acid.
    Penno CA; Morgan SA; Vuorinen A; Schuster D; Lavery GG; Odermatt A
    J Lipid Res; 2013 Oct; 54(10):2874-83. PubMed ID: 23933573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of microsomal cortisol production by (-)-epigallocatechin-3-gallate through a redox shift in the endoplasmic reticulum--a potential new target for treating obesity-related diseases.
    Szelényi P; Révész K; Konta L; Tüttõ A; Mandl J; Kereszturi É; Csala M
    Biofactors; 2013; 39(5):534-41. PubMed ID: 23554216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
    Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of methoxychlor and its metabolite 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane on 11β-hydroxysteroid dehydrogenase activities in vitro.
    Guo J; Deng H; Li H; Zhu Q; Zhao B; Chen B; Chu Y; Ge RS
    Toxicol Lett; 2013 Mar; 218(1):18-23. PubMed ID: 23333641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of stress on hepatic 11beta-hydroxysteroid dehydrogenase activity and its influence on carbohydrate metabolism.
    Altuna ME; Lelli SM; San Martín de Viale LC; Damasco MC
    Can J Physiol Pharmacol; 2006 Oct; 84(10):977-84. PubMed ID: 17218963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment.
    Piccirella S; Czegle I; Lizák B; Margittai E; Senesi S; Papp E; Csala M; Fulceri R; Csermely P; Mandl J; Benedetti A; Bánhegyi G
    J Biol Chem; 2006 Feb; 281(8):4671-7. PubMed ID: 16373343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that adrenal hexose-6-phosphate dehydrogenase can effect microsomal P450 cytochrome steroidogenic enzymes.
    Foster CA; Mick GJ; Wang X; McCormick K
    Biochim Biophys Acta; 2013 Sep; 1833(9):2039-44. PubMed ID: 23665046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation.
    Lavery GG; Walker EA; Draper N; Jeyasuria P; Marcos J; Shackleton CH; Parker KL; White PC; Stewart PM
    J Biol Chem; 2006 Mar; 281(10):6546-51. PubMed ID: 16356929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11β-hydroxysteroid dehydrogenase 1.
    Nishihara M; Takahashi J; Kondo T; Mouri K; Asahi S
    Drug Res (Stuttg); 2014 Sep; 64(9):476-84. PubMed ID: 24357138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
    Stambergova H; Skarydova L; Dunford JE; Wsol V
    Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fructose increases corticosterone production in association with NADPH metabolism alterations in rat epididymal white adipose tissue.
    Prince PD; Santander YA; Gerez EM; Höcht C; Polizio AH; Mayer MA; Taira CA; Fraga CG; Galleano M; Carranza A
    J Nutr Biochem; 2017 Aug; 46():109-116. PubMed ID: 28499147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of experimental kidney disease on the functional expression of hepatic reductases.
    Alshogran OY; Naud J; Ocque AJ; Leblond FA; Pichette V; Nolin TD
    Drug Metab Dispos; 2015 Jan; 43(1):100-6. PubMed ID: 25332430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.